ArticleJournal of neurochemistry2015

Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.

Kristine E Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.